• Home
• About Us
• Aesthetic Medicine Training
  • Botox Training
  • Hands-On Botox and Dermal Filler Training
  • MedSpa / Aesthetic Practice Business Traininig
• Resources
  • Magazines and Periodicals and Other Links
  • More Resources
  • Associations
  • Events
  • International Aesthetic Medicine Resources
  • Archives
• Consumer Information

Subscribe

SmartLipo on ABC News

WHAT IS SMARTLIPO?

Is a treatment literally melts away fat in trouble spots like your abdomen, thighs, arms and neck. The results last longer than dieting or exercise and since the treatment is minimally invasive.

The SmartLipo procedure is the first laser-assisted liposuction procedure. SmartLipo was approved by the FDA in November of 2006..

               

Nevada Medical Board responds to Botox and Hepatitis Scare

This to clarify and update the reader concerning the activities of the Nevada State Board of Medical Examiners related to the hepatitis C infections at the Endoscopy Center of Southern Nevada and related clinics. It seems that in the rush to blame someone or something for this tragedy, the Board has been inaccurately accused for not taking prompt action when in fact it is the only State agency that has taken formal, decisive action. Read more

               

Niche Marketing in the Aesthetic Practice

Targeting specific groups of patients in your business and marketing directly to them can distinguish you from your competitors and increase revenues. Careful study of treatments specifically designed for skin type IV-VI is crucial to the safe and effective treatment of Asian, Indian, bi-racial and African American clients. Being an expert in these treatments brings loyal and repeat clients that are very happy and go on to tell other friends and family members in their community. Read more

               

Botox: Pros & Cons

Better TV talks to Dr. Irwin about the pros and cons of fighting wrinkles with Botox.

               

Medicis to Acquire LipoSonix

Medicis and LipoSonix, Inc. today jointly announced they have entered into a definitive merger agreement under which Medicis will acquire LipoSonix, an independent, privately-held company with a staff of approximately 40 scientists, engineers and clinicians located near Seattle, Washington. As a result of the acquisition, Medicis will broaden its aesthetics portfolio pipeline with LipoSonix’s body contouring technology. This completely non-invasive, focused ultrasound technology is designed to treat troublesome areas of fat which may not respond well to diet or exercise. LipoSonix recently launched its first product in Europe, where it is being marketed and sold through distributors. Subject to approval by the U.S. Food and Drug Administration (FDA), Medicis anticipates entering the potentially lucrative U.S. marketplace with the LipoSonix technology in the 2011 timeframe, if not sooner. Read more

               

Primary care doctors are getting into the beauty business

A man with a large vein running across his nose wears a huge mustache, hoping to make the vein less noticeable. A woman with dark facial pigmentation walks with her head down and wears her hair long, so it swings forward to cover her face. Hardly Hollywood hunks and starlets, these are regular folks who simply want to feel better about themselves and who, according to the Minnesota physicians who treat them, are driving the growth of aesthetic medicine. Read more

               

Key to Angelina-like Cheeks - Add Volume to Deep Fat Compartment

ASPS Study Says Discovery of Deep Fat Compartment Essential to Facial Rejuvenation

ARLINGTON HEIGHTS, Ill. – Not only are cheeks central to your face – they are central to the American concept of beauty. A study in June’s Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS), found that a deep fat compartment located within the cheek is vital to a youthful-looking face. Not only does rejuvenating or returning volume to this fat compartment make the cheek more youthful, it also improves volume loss under the eyes, helps eliminate “parentheses” lines around the nose and mouth and gives more curve to the upper lip – essentially restoring a youthful appearance to the overall face. Read more

               

Cosmetic Procedures Still Booming Despite Economy Concerns

New Survey by the American Society for Dermatologic Surgery Reveals Fillers, Laser-Related and Injectable Toxin Procedures Continue to Rise.

Despite concerns that the U.S. economy is heading toward a recession, procedures that make consumers feel good and confident about the way they look continue to be in demand according to a new survey released today by the American Society for Dermatologic Surgery (ASDS).

Nearly 63 percent of member respondents are maintaining a consistent volume of bookings for existing patients seeking cosmetic-related procedures compared to six months ago, while 24 percent had indicated an increase. Additionally, nearly 32 percent of dermatologic surgeons indicated that the number of new patients making appointments had increased by up to 30 percent. Read more

               

Five-year clinical data for soft volume filler presented at ASAPS annual meeting

San Diego — Medical News Today reports that Danish firm Contura International A/S presented five-year clinical data for its soft volume filler Aquamid at the annual meeting of the American Society of Aesthetic Plastic Surgery (ASAPS), held here recently.

Aquamid is used to rejuvenate or contour the face, either by restoring lost volume or by adding extra volume. Contura is currently conducting a multicenter, comparative clinical trial of Aquamid in the United States.

The five-year study presented at the ASAPS meeting is a multicenter, prospective study of safety and long-term aesthetic results of Aquamid injections for facial soft-tissue augmentation and facial contouring. A total of 116 patients attended the clinics for follow-up five years after their first injection.

According to the trial report, 96 percent of the 116 patients evaluated after five years had “very good” or “good” aesthetic results, and 92 percent said they were “very satisfied” or “satisfied” with the results. The trial’s safety data showed that injection of Aquamid over a five-year period resulted in few adverse events.

Aquamid currently is available in 40 countries and is under clinical investigation in the United States. Data from this trial will support a PMA application with the FDA.

               

ScarArt Business Launched to Creatively Camouflage Abdominal Scars

ScarArt is a specially designed temporary tattoo to fit horizontal tummy tuck and c-section scars. It is made with FDA REGULATED ADHESIVES AND COLORS. It is waterproof, smear proof and was designed to last 1-3 days. It can be applied and removed whenever you choose. Read more

               

Next Page »

IAPAM Aesthetic Medicine Resources

• Recent News

  • Syneron Announces New Ground Breaking evolastin(TM) Procedure
  • Cynosure Receives FDA 510(k) Clearance for Cellulaze Cellulite Laser Workstation
  • IAPAM’s hCG Physician Medical Weight Management Training - March 2, 2012
  • Botox/Dermal Filler Training- February 18-19, 2012
  • Advanced Dermal Filler Training- February 17, 2012
  • IAPAM Aesthetic Practice Startup Workshop - March 5, 2012
  • IAPAM Announces NEW hCG Training Resource: IAPAM’s hCG Q & A e_Book
  • Doctors can enjoy variety of advantages from implementing EMR after initial learning curve
  • Stop the Clock: Lift and Tighten Without the Knife
  • Botulinum Toxin Used on Perioral ‘Bar Code’

Copyright © 2010 Aesthetic Medicine News · Sitemap · Privacy Policy & Terms of Use · Login